Optimal adjuvant therapy in elderly glioblastoma: results from a systematic review and network meta-analysis.

Babusha KalraSadhana KannanTejpal Gupta

Published in: Journal of neuro-oncology (2020)

Moderately hypofractionated RT (3-weeks) with concurrent and adjuvant temozolomide is the most optimal and preferred adjuvant therapeutic regimen in elderly GBM.

Keyphrases

early stage
middle aged
community dwelling
radiation therapy
small cell lung cancer
squamous cell carcinoma
brain metastases